Axcella Health (AXLA) Financials

$0.40

$-0.04 (-8.89%)

As on 29-Dec-2023 16:00EDT

Market cap

$1 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

19.1

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Operating Revenue	--	--	--	--	--	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Operating Expenses	41.58	72.80	61.85	53.84	57.44	33.90
Operating Profit (EBIT)	-45.77	-76.99	-61.85	-53.84	-57.44	-33.90
Other Income	0.21	--	--	0.32	--	--
Profit before Tax	-48.23	-81.19	-64.63	-56.53	-59.04	-36.07
Provision for Tax	1.80	1.18	2.49	2.28	0.94	-2.17
Profit after Tax (Net Income)	-50.03	-82.36	-67.12	-58.81	-59.97	-36.07
Minority Interest	--	--	--	--	--	--
Consolidated Profit	-28.08	--	-64.63	-56.53	-59.08	-36.22

Liabilities ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Shareholder's Funds	-2.26	4.16	22.01	75.38	60.22	48.51
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	--	0.62	25.57	34.21	25.78	26.42
Current Liabilities	11.54	14.15	10.15	7.78	8.36	6.91
Total Liabilities	20.82	18.93	57.73	109.59	94.36	81.84

Assets ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Non-Current Assets	0.02	1.78	2.68	2.26	2.31	1.54
Current Assets	9.27	17.15	55.05	107.33	92.05	80.30
Total Assets	20.82	18.93	57.73	109.59	94.36	81.84
Total Debt*	1.39	2.16	25.07	25.22	24.90	24.95
Net Current Assets	-2.27	3.88	46.50	101.24	85.18	73.39

Cashflow ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Cash From Operating Activities	--	-69.59	-54.22	-49.77	-50.96	-30.71
Cash Flow from Investing Activities	--	30.92	3.05	-36.12	-0.12	-0.59
Cash from Financing Activities	--	32.24	3.16	65.43	63.67	63.95
Net Cash Inflow / Outflow	--	--	--	-20.46	--	--

Financials Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Adjusted EPS ($)	-0.90	-1.52	-1.73	-1.57	-2.59	-1.57
Cash EPS ($)	--	-1.51	-1.72	-1.56	-2.56	-1.52
Adjusted Book Value ($)	--	0.08	0.57	2.01	2.60	2.11
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-1.28	-1.40	-1.33	-2.20	-1.34
Free Cash Flow per Share ($)	--	-1.29	-1.40	-1.33	-2.21	-1.36

Profitability Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
ROCE (%)	--	-308.46	-90.90	-63.33	-75.64	314.66
ROE (%)	--	-629.40	-137.83	-86.74	-110.31	106.34
ROA (%)	-113.73	-214.90	-80.23	-57.67	-68.07	-55.21
EBIT Margin (%)	--	--	--	--	--	--
Net Margin (%)	-23,822.86	--	--	-18,610.44	--	--
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Revenue Growth (%)	--	--	--	--	--	--
EBIT Growth (%)	35.87	-24.48	-14.88	6.27	-69.53	-16.83
Net Profit Growth (%)	33.51	-22.71	-14.13	1.94	-66.27	-16.58
EPS Growth (%)	49.16	0.12	-0.10	0.40	-0.65	--
Book Value Growth (%)	-117.34	--	--	--	--	--

Valuation Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Price / Earnings	--	-0.22	-1.21	-3.31	-1.55	--
Price / Book Value	19.10	4.28	3.69	2.58	1.54	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	0.14	-0.04	-0.83	-2.11	-0.45	--
Close Price ($)	5.45	8.20	52.25	129.75	100.25	--
High Price ($)	68.50	72.25	171.00	193.25	399.75	--
Low Price ($)	4.05	4.05	51.50	56.25	69.00	--
Market Cap ($ Cr)	1.18	--	--	--	--	--

Solvency Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Debt to Equity	--	0.52	1.14	0.33	0.41	0.51
Short term debt to equity ratio	-0.62	0.38	--	--	--	--
Current Ratio	0.80	1.21	5.42	13.79	11.02	11.62
Quick Ratio	0.80	--	--	--	--	11.62
Interest Coverage	-26.22	-25.48	-21.20	-17.90	-16.92	--

Operating Efficiency Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	--	--	--	--	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	--	--	--	--
Payable days	--	--	--	--	--	--
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.